高级检索
当前位置: 首页 > 详情页

Responses of smoking and nonsmoking cancer patients to drug treatment A protocol for systematic review and meta-analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Basic Medicine, Inner Mongolia Medical University, Jinshan Development Zone, Huhhot, Inner Mongolia, P.R. China, [2]Department of Orthopedic Surgery and Biomedical Engineering, The University of Tennessee Health Science Center, Memphis, TN, USA, [3]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, [4]Beijing Cancer Hospital and Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute, Beijing, P.R. China, [5]Department of Medicine, Division of Connective Tissue Diseases, The University of Tennessee Health Science Center, [6]Research Service, Memphis VA Medical Center, Memphis, TN, USA.
出处:
ISSN:

关键词: cancer hazard ratio lung patients smoking

摘要:
Introduction: Smoking is well-known to increase cancer risk, particularly risk of lung cancer, and negatively affects efficacy of cancer treatment. However, recent evidence suggests that among cancer patients, paradoxically, smokers respond to treatment better than non-smokers. We propose to conduct a focused review and meta-analysis to compare response to drug treatment between smoking and non-smoking cancer patients. Methods and design: We will collect data from large clinical trials of therapies for cancer patients which have included smokers and non-smokers. We will search PubMed, PMC/ MEDLINE, SCOPUS, Embase, and the registries for clinical trials and four major clinical journals up to June 30, 2019. Search terms will be "Drug name" phase-3" or "Drug name" phase-III." Data collection will be focused on randomized clinical trials of cancer drugs that enrolled at least 100 participants and reporting treatment results from smoking and nonsmoking patients. Initial selection criteria will be clinical trial studies of drug treatment of 100 or more cancer patients, and reporting hazard ratios (HR) for smokers and non-smokers. Two persons will be searching such publications independently, or data will be provided, double checked, or confirmed by authors. Multiple sub-group analyses will be conducted by at least two persons to avoid bias or experimental errors. Discussion: The results will clarify whether smoking and response to treatment of cancer are linked not. Our results may possibly identify drug/s that work better among cancer patients who are smokers.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
JCR分区:
出版当年[2020]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2024]版:
Q2 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Basic Medicine, Inner Mongolia Medical University, Jinshan Development Zone, Huhhot, Inner Mongolia, P.R. China, [2]Department of Orthopedic Surgery and Biomedical Engineering, The University of Tennessee Health Science Center, Memphis, TN, USA,
共同第一作者:
通讯作者:
通讯机构: [2]Department of Orthopedic Surgery and Biomedical Engineering, The University of Tennessee Health Science Center, Memphis, TN, USA, [3]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, [6]Research Service, Memphis VA Medical Center, Memphis, TN, USA. [*1]Department of Orthopedic Surgery and Biomedical Engineering, The University of Tennessee Health Science Center College of Medicine, Memphis, TN 38103, USA [*2]Research Center, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, Hebei 050011, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号